Switch to:
More From Other Websites
[video] Obesity treatment sales fall short Aug 18 2014
ARENA PHARMACEUTICALS INC Financials Aug 15 2014
ARENA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 06 2014
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss Aug 04 2014
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 01 2014
Q2 2014 Arena Pharmaceuticals Earnings Release - After Market Close Aug 01 2014
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results Aug 01 2014
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3... Jul 30 2014
Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for... Jul 29 2014
Arena Sees Belviq Sales Climb Despite Seasonality Jul 25 2014
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on... Jul 25 2014
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jul 21 2014
Arena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary Jul 21 2014
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in... Jul 21 2014
Arena Stock Rises With Expected Jump In Belviq Sales Jul 18 2014
Arena Pharmaceuticals' Pain Candidate Gets New U.S. Patent Jul 16 2014
Arena Gives Pipeline Exposure - Is The Company Partner Shopping? Jul 16 2014
Arena Pharmaceuticals granted patent for Cannabinoid Receptor Modulators Jul 15 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK